Another two studies that did not define the tumor pathology showed that TGF-β overexpression might be a strong predictor of poor survival for NSCLC patients (HR = 2.04, 95% CI: 1.12–3.72) (Fig. 3). Here, TGFB1 is linked to neoplasm.